Latest Sysmex Corp ADR (SSMXY) Headlines Concis
Post# of 4
Posted On: 03/11/2014 12:49:47 PM
Latest Sysmex Corp ADR (SSMXY) Headlines
Concise Analysis of the International In Vitro Diagnostic (IVD) Market - Forecast To 2017
M2 - Tue Mar 11, 6:07AM CDT
Research and Markets (http://www.researchandmarkets.com/research/nc4zfn/in_vitro) has announced the addition of the "Concise Analysis of the International In Vitro Diagnostic (IVD) Market - Forecast To 2017" report to their offering. The in vitro diagnostic market studied in this report has been segmented by technology, product type, application, end user, and geography. The technology market is further segmented into clinical chemistry, immunochemistry, molecular diagnostics, hematology, coagulation, microbiology, and others, of which immunochemistry accounted for the largest share with 25.8% in 2010. By product type, the IVD market has segments like instruments, reagents, data management software/hardware, and services. Based on applications, the in vitro diagnostic market is segmented as diabetes, infectious diseases, oncology, cardiology, nephrology, auto-immune diseases, AIDS, drug testing, and others. Laboratory testing, hospital testing, academic (AMCs and university) testing, point-of-care testing, patient self-testing, and others comprise the end-user segment of the IVD market. The global in vitro diagnostic market was valued at $49.2 billion in 2012 and is expected to reach $69.1 billion by 2017, at a CAGR of 7% from 2012 to 2017. The IVD market is primarily driven by rising incidences of chronic and infectious diseases in emerging economies, a rapidly aging population, the rise in point-of-care testing, and the rising importance of personalized medicine. However, factors such as stringent regulatory frameworks and a shortage of budget and labor are restraining the growth of the market. Key Topics Covered: 1 Introduction 2 Executive Summary 3 Market Overview 4 Global In Vitro Diagnostic Market, By Technique 5 Global In Vitro Diagnostic Market, By Product Type 6 Global In Vitro Diagnostic Market, By Application 7 Global In Vitro Diagnostic Market, By End-User 8 Geographic Analysis 9 Competitive Landscape 10 Company Profiles Companies Mentioned: - Abbott Laboratories, Inc - Alere, Inc - Arkray, Inc - Bayer AG - Becton, Dickinson And Company - Bio-Rad Laboratories, Inc - Biomerieux - Danaher Corporation - Diagnostica Stago Sas - Diasorin SPA - Hologic, Inc - Horiba, Ltd - Johnson & Johnson - Novartis International Ag - Qiagen NV - Roche Diagnostics Limited - Siemens Healthcare - Sysmex Corporation - Thermo Fisher Scientific, Inc For more information visit http://www.researchandmarkets.com/research/nc4zfn/in_vitro
Global Endocrine Testing Market to 2019: E2, FSH, hCG, LH, DHEAS, Progesterone, Testosterone, TSH, Prolactin, Cortisol, Insulin Tests
M2 - Wed Feb 26, 9:04AM CST
Research and Markets (http://www.researchandmarkets.com/research/bk2st3/endocrine_testing) has announced the addition of the "Global Endocrine Testing Market to 2019: E2, FSH, hCG, LH, DHEAS, Progesterone, Testosterone, TSH, Prolactin, Cortisol, Insulin Tests" report to their offering. Endocrinology, a branch of medicine deals with the study of structural and functional elements of the endocrine system. This system comprises endocrine glands (thyroid, adrenal, pituitary and others) and secretory organs (pancreas, hypothalamus) that release hormones directly into the blood stream and regulate the body functioning. Endocrine testing market is studied by three major segments namely, by test, by diagnostic technologies and by end users. The test segment is further classified into 11 major hormone tests that includes estradiol (E2), Follicle Stimulating Hormone (FSH), Human Chorionic Gonadotropin (hCG), Luteinizing hormone (LH), Dehydroepiandrosterone sulfate (DHEAS), progesterone, testosterone, Thyroid Stimulating Hormone (TSH), prolactin, cortisol and insulin tests. The market accounts for a wide range of conventional as well as rapid diagnostic kits used for detecting deficiency (hyposecretion) or excess (hypersecretion) secretions of these hormones. The diagnostic technologies segment further describes the technological platforms used in the analysis of the specimen test sample (blood, urine, etc) and is further categorized into five major technologies, tandem mass spectrometry, immunoassay, monoclonal and polyclonal antibody, sensor and clinical chemistry technologies. The end user segment elucidates the endocrine testing market by various end users that includes hospitals, commercial laboratories, ambulatory health care centers, home based tests and physician's offices. The global endocrine testing market is segmented into the following categories: Tests - Estradiol (E2) Test - Follicle Stimulating Hormone (FSH) Test - Human Chorionic Gonadotropin (hCG) Test - Luteinizing Hormone (LH) Test - Dehydroepiandrosterone sulfate (DHEAS) Test - Progesterone Test - Testosterone Test - Thyroid Stimulating Hormone (TSH) Test - Prolactin Test - Cortisol Test - Insulin Test - Others (Gastrin, Thymosin, Secretin, etc.) Diagnostic Technologies - Tandem Mass spectrometry - Immunoassay (Enzyme immunoassays, Radioimmunoassays (RIA)) Technologies - Monoclonal and Polyclonal Antibody Technologies - Sensor (Electrochemical, Biosensors, etc.) Technologies - Clinical Chemistry Technologies - Others (Liquid Chromatography Mass Spectrometry (LC-MS), High performance Liquid Chromatography (HPLC), etc.) Location - Hospitals - Commercial Laboratories - Ambulatory Care Centers - Home Based Tests - Physician Offices Key Topics Covered: Chapter 1 Preface Chapter 2 Executive Summary Chapter 3 Market Overview Chapter 4 Endocrine Testing Market, by Test Chapter 5 Endocrine Testing Market, by Diagnostic Technologies Chapter 6 Endocrine Testing Market, by End Users Chapter 7 Endocrine Testing Market, by Geography Chapter 8 Competitive Landscape Chapter 9 Recommendations Chapter 10 Company Profiles Companies Mentioned - Abbott Laboratories - AB SCIEX LLC - Agilent Technologies - Biomedical Diagnostics - bioMerieux - Bio-Rad Laboratories, Inc. - DiaSorin S.p.A - F. Hoffmann-La Roche Ltd. - Laboratory Corporation of America Holdings (LabCorp) - Ortho Clinical Diagnostics - Quest Diagnostics - Siemens Healthcare - Sysmex Corporation - Thermo Fisher Scientific For more information visit http://www.researchandmarkets.com/research/bk2st3/endocrine_testing
Concise Analysis of the International Pico Projectors Market - Forecasts to 2016
M2 - Tue Feb 04, 3:23AM CST
Research and Markets (http://www.researchandmarkets.com/research/vjgw5g/global_pico) has announced the addition of the "Concise Analysis of the International Pico Projectors Market - Forecasts to 2016" report to their offering. Analysts forecast the Global Pico Projectors market to grow at a CAGR of 32.7 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increasing integration of pico projectors in mobile handsets. The Global Pico Projectors market has also been witnessing increasing adoption of embedded pico projectors. However, limited features in pico projectors could pose a challenge to the growth of this market. "Concise Analysis of the International Pico Projectors Market - Forecasts to 2016", has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market in the Americas, the EMEA, and the APAC regions; it also covers the Global Pico Projectors market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market. The key vendors dominating this market space include 3M Co., MicroVision Inc., Optoma Corp., Syndiant Inc., and Texas Instruments Inc. The other vendors mentioned in this report are AAXA Technologies Inc., Acer Inc., Aiptek Inc., bTendo Ltd., Greenlight Optics LLC., Lemoptix SA., Light Blue Optics Ltd., Luminus Device Inc., Maradin Ltd., Mezmeriz Inc., Micron Technology Inc., Opus Microsystems Corp., Samsung Electronics Co. Ltd., Toshiba Corp., and WowWee Group Ltd. Key Topics Covered: 1. Executive Summary 2. List of Abbreviations 3. Introduction 4. Research Methodology 5. Scope of the Report 6. Market Landscape 7. Geographical Segmentation 8. Vendor Landscape 9. Buying Criteria 10. Market Growth Drivers 11. Drivers and their Impact 12. Market Challenges 13. Impact of Drivers and Challenges 14. Market Trends 15. Key Vendor Analysis 16. Other Reports in this Series Companies Mentioned: - 3M - AAXA Technologies. - Acer - Aiptek - Greenlight Optics - Lemoptix - Light Blue Optics - Luminus Device - Maradin - Mezmeriz - MicroVision - Micron Technology - Optoma - Opus Microsystems - Samsung Electronics - Syndiant - Texas Instruments - Toshiba - WowWee Group - bTendo For more information visit http://www.researchandmarkets.com/research/vjgw5g/global_pico
Black Alliance for Educational Options Applauds the Center for Education Reform for Insightful Report on Charter Schools
Marketwire - Thu Jan 30, 1:41PM CST
The Black Alliance for Educational Options (BAEO) applauds the Center for Education Reform (CER) for the release of their Survey of America's Charter Schools. The 23-page report provides an in-depth analysis of charter school students, operations, and teachers, and discusses trends over time in the Size and Scope, Demographics, Finance and Operations, and Academic Program of charter schools and insights into why demand for these independent schools has grown.
2013 Report on the International Cell Surface Markers Market - Trends and Forecasts to 2018
M2 - Fri Jan 24, 6:24AM CST
Research and Markets (http://www.researchandmarkets.com/research/ccmnwh/cell_surface) has announced the addition of the "2013 Report on the International Cell Surface Markers Market - Trends and Forecasts to 2018" report to their offering. Cell surface markers serve as the prime component in identification and categorization of cells such as lymphocytes, macrophages, monocytes, tumor cells and other cells majorly related to immunology. Cell surface marker analysis is performed through the use of technologies namely, flow cytometry and hematology analyzers and can be carried out on various samples such as lymph nodes, blood, bone marrow and other tissues. Such analysis may allow simplification of disease diagnosis and identification, sample preparation and drug discovery. Identification of specific types of molecules through cell surface marker analysis helps in efficient disease diagnosis and thereby assists in determination of disease treatment and drugs. Cell surface markers analysis enables the quantification of the scope of new drugs reaching the intended target and are also responsible for achieving the clinical outcomes by altering the proposed pathophysiological mechanisms. Disease diagnosis by detection or use of cell surface markers has been beneficial and critical in developing innovative and reliable indicators with high specificity for the diagnosis and prognosis of different types of diseases, majorly cancer. Companies investing heavily in developing automated systems with improved sample processing and analysis may gain greater benefits in the near future. Introduction of new and cost-effective instruments is further facilitating the growth of new market entrants and is also being achieved via showcasing advantages of the software and technical capabilities of their instruments at various conferences, laboratories, trade shows, web casting and electronic newsletters. Key Topics Covered: 1 Introduction 2 Executive Summary 3 Market Overview 4 Global Cell Surface Markers Market, by Instruments and Reagents 5 Global Cell Surface Markers Market, by Applications 6 Global Cell Surface Markers Market, by Geography 7 Recommendations 8 Company Profiles Companies Mentioned: - Abbott Laboratories - BD Biosciences - Beckman Coulter - Bio-Rad Laboratories - F Hoffmann-La Roche - Grifols - Immucor - Janssen Diagnostics - Nihon Kohden Corporation - Siemens Healthcare - Sysmex Corporation - Thermo Fischer Scientific For more information visit http://www.researchandmarkets.com/research/ccmnwh/cell_surface
Do You Know How to Read a Report Card?
by Charles Ekyagonza - All Africa Global Media - Fri Jan 17, 1:44AM CST
At the end of every term, learners are given report cards as a way of evaluating their work and behaviour during the term.
Akingbola Challenges Lagos Court's Jurisdiction to Register London Judgment Against Him
by Davidson Iriekpen - All Africa Global Media - Fri Jan 17, 1:37AM CST
A former Managing Director of the defunct Intercontinental Bank Plc., Mr. Erastus Akingbola, has challenged the jurisdiction of a Lagos High Court to register a GBP654 million judgment delivered against him by a London court.
Kwadaso MP Embarks On Road Maintenance Program
All Africa Global Media - Thu Jan 16, 12:02PM CST
From Issah Alhassan, Kumasi THE MEMBER of Parliament for the Kwadaso Constituency, Dr. Owusu Afriyie Akoto, has launched a community infrastructural initiative programme aimed at addressing the overwhelming road infrastructure challenges confronting commuters and drivers in the constituency.
Brendan Ives has been appointed as a new President of TeliaSonera International Carrier. (TSIC)
M2 - Tue Jan 14, 8:52AM CST
Originally from New Zealand, Brendan has been working in key roles at TSIC since 2001.
Global Immunoassay Market Report - World Forecasts to 2018
M2 - Mon Jan 06, 4:09AM CST
Research and Markets (http://www.researchandmarkets.com/research/88b6j7/immunoassay) has announced the addition of the "Global Immunoassay Market Report - World Forecasts to 2018" report to their offering. Immunoassay has evolved as an integral part of the modern medical care practice owing to the continuous technological advancements in this field, the increase in healthcare awareness among people, and the increasing use of immunoassay tests in diagnosis and monitoring. This research report categorizes the global on the basis of technology, application, product (analyzers and reagents), and end users. On the basis of technology, the enzyme immunoassay segment accounted for the largest share of the global market in 2012. Long-term presence in the market, high sensitivity for infectious/viral disease testing, and the huge demand from developing countries due to the lower costs of enzyme immunoassay in comparison to chemiluminescence immunoassay (CLIA) are all factors that are responsible for its growing share in the market. On the basis of product, the reagents market accounted for the largest share of this market in 2012. The accessibility of a wide range of reagents and the need for reliable, specific, and faster detection of chronic diseases at early stages are factors that are expected to drive the immunoassay reagents market. Key Topics Covered: 1 Introduction 2 Executive Summary 3 Premium Insights 4 Industry Analysis & Market Overview 5 Immunoassay Market, By Technology 6 Immunoassay Market, By Products (Analyzers & Reagents) 7 Immunoassay Market, By Application 8 Global Immunoassay Market, By End-Users 9 Geographic Analysis 10 Competitive Landscape 11 Company Profiles Companies Mentioned: - Abbott Laboratories, Inc - Alere, Inc - Becton, Dickinson And Company - Biom?rieux - DRG International, Inc - Danaher Corporation (Beckman Coulter) - Diasorin SPA - Diasource Immunoassays SA - Hologic (Gen-Probe ) - IBL International GMBH - IDS Plc - Meridian Life Science, Inc - Ortho Clinical Diagnostics (A J&J Company) - Qiagen NV - Roche Diagnostics Limited - Siemens Healthcare - Sysmex Corporation - Thermo Fisher Scientific, Inc (Brahms) For more information visit http://www.researchandmarkets.com/research/88b6j7/immunoassay
2013 Report on the International In Vitro Diagnostic (IVD) Market - Includes Forecast To 2017
M2 - Fri Jan 03, 5:34AM CST
Research and Markets (http://www.researchandmarkets.com/research/wxrj4l/in_vitro) has announced the addition of the "2013 Report on the International In Vitro Diagnostic (IVD) Market - Includes Forecast To 2017" report to their offering. In 2012, the Americas had accounted for the largest share of the global in vitro diagnostic market, followed by Europe. However, the BRIC countries represent the fastest-growing markets due to the economic growth, the rising number of chronic diseases, and an increasing awareness about the use of IVD tests to control the spread of diseases. Moreover, the economic slowdown, pricing pressures, and high competition in mature countries will compel companies to focus on emerging markets. This research report categorizes the global IVD (In vitro diagnostic) market on the basis of technique, product type, application, and end-users. These markets are broken down into segments and sub-segments, providing exhaustive value analysis for 2010, 2011 and 2012, as well as forecast up to 2017. Each of the devices market is comprehensively analyzed at a granular level by geography (North America, Europe, BRIC, Japan and Rest of the World) to provide in-depth information on the global scenario. These regions are further analyzed at major country levels. The key players are Abbott Laboratories, Inc. (U.S.), Roche Diagnostics Limited (Switzerland), Becton, Dickson and Company (U.S.), Siemens Healthcare (Germany), Diagnostica Stago SAS (France), Danaher Corporation (U.S.), Thermo Fisher Scientific, Inc. (U.S.), ARKRAY, Inc. (Japan), Bio-Rad Laboratories, Inc. (U.S.), DiaSorin S.p.A. (Italy), Sysmex Corporation (Japan), bioM?rieux (France), HORIBA, Ltd. (Japan), and Alere, Inc. (U.S.). Key Topics Covered: 1 Introduction 2 Executive Summary 3 Market Overview 4 Global In Vitro Diagnostic Market, By Technique 5 Global In Vitro Diagnostic Market, By Product Type 6 Global In Vitro Diagnostic Market, By Application 7 Global In Vitro Diagnostic Market, By End-User 8 Geographic Analysis 9 Competitive Landscape 10 Company Profiles Companies Mentioned: - Abbott Laboratories - Alere - Arkray - Bayer - Becton, Dickinson And Company - Bio-Rad Laboratories - Biomerieux - Danaher Corporation - Diagnostica Stago - Diasorin SPA - Hologic - Horiba - Johnson & Johnson - Novartis International - Qiagen NV - Roche Diagnostics Limited - Siemens Healthcare - Sysmex Corporation - Thermo Fisher Scientific For more information visit http://www.researchandmarkets.com/research/wxrj4l/in_vitro
Global Cell Surface Markers Market to 2018: Flow Cytometers, Hematology Analyzers, Reagents And Kits
M2 - Thu Nov 28, 10:25AM CST
Research and Markets (http://www.researchandmarkets.com/research/b2t35p/cell_surface) has announced the addition of the "Global Cell Surface Markers Market to 2018: Flow Cytometers, Hematology Analyzers, Reagents And Kits" report to their offering. Cell surface markers are unique to cell types and have vital functional role in immunology. These are generally antigens or molecules present within the plasma membrane of the cell. Such markers serve as the prime component in identification and categorization of cells such as lymphocytes, macrophages, monocytes, tumor cells and other cells majorly related to immunology. Cell surface marker analysis is performed through the use of technologies namely, flow cytometry and hematology analyzers and can be carried out on various samples such as lymph nodes, blood, bone marrow and other tissues. Such analysis may allow simplification of disease diagnosis and identification, sample preparation and drug discovery. Identification of specific types of molecules through cell surface marker analysis helps in efficient disease diagnosis and thereby assists in determination of disease treatment and drugs. Cell surface markers analysis enables the quantification of the scope of new drugs reaching the intended target and are also responsible for achieving the clinical outcomes by altering the proposed pathophysiological mechanisms. Disease diagnosis by detection or use of cell surface markers has been beneficial and critical in developing innovative and reliable indicators with high specificity for the diagnosis and prognosis of different types of diseases, majorly cancer. High-throughput tools and techniques in addition to miniature and robust instruments with manifold applications have been the recent need to meet requirements of both research and clinical sectors. Companies investing heavily in developing automated systems with improved sample processing and analysis may gain greater benefits in the near future. Introduction of new and cost-effective instruments is further facilitating the growth of new market entrants and is also being achieved via showcasing advantages of the software and technical capabilities of their instruments at various conferences, laboratories, trade shows, web casting and electronic newsletters. At present, a broad range of assay technologies and solutions for cell surface marker research are available in the market to enable the analysis of gene expression and regulation, genotyping, signal transduction and epigenetic modifications. Some of the most common solutions available for cell surface marker analysis are PCR array, miRNA, pathway reporter, mutation analysis, DNA methylation and protein expression. Complexity of high-end flow cytometers and expensive reagents, controls and analysis systems results into lowering the adoption of sophisticated cell marker analysis solutions, particularly in economically lagged countries. Thus rising preference for lowering healthcare spending by cost containment in diagnosis procedures coupled with rapid and efficient decision making for therapies of specific diseases will further aid in sustaining the growing acceptance of cell surface marker analysis worldwide. Geographically, North America dominates the global cell surface markers market. As majority of the prime players in the market are domiciled in North America, many technological advancements first are introduced in this region. Growing acceptance of cell surface markers analysis by major industries and verified efficiency in clinical laboratories drives the market for cell surface markers in North America. In addition, factors such as increased market consolidation, simplification of analysis process, cost containment of instruments and reagents and introduction of cheaper products will result in rapid adoption of research in cell surface markers field in the emerging markets. Furthermore, increase in healthcare awareness, affordability, better patient rehabilitation, growth in medical tourism and less competition levels than developed markets will result in growth in demand for identification of cell surface markers and associated disease diagnosis and treatment in emerging economies. Key Topics Covered: Chapter 1 Introduction Chapter 2 Executive Summary Chapter 3 Market Overview Chapter 4 Global Cell Surface Markers Market, by Instruments and Reagents Chapter 5 Global Cell Surface Markers Market, by Applications Chapter 6 Global Cell Surface Markers Market, by Geography Chapter 7 Recommendations Chapter 8 Company Profiles - Abbott Laboratories, Inc - BD Biosciences - Beckman Coulter, Inc - Bio-Rad Laboratories, Inc - F Hoffmann-La Roche Ltd - Grifols SA - Immucor, Inc - Janssen Diagnostics, Inc - Nihon Kohden Corporation - Siemens Healthcare - Sysmex Corporation - Thermo Fischer Scientific, Inc For more information visit http://www.researchandmarkets.com/research/b2t35p/cell_surface
Global Hematology Analyzers Market 2012-2016: Featuring Top Sellers such as Sysmex Corp and Becton Dickinson & Co.
M2 - Wed Nov 27, 11:17AM CST
Research and Markets (http://www.researchandmarkets.com/research/lf8chh/global_hematology) has announced the addition of the "Global Hematology Analyzers Market 2012-2016" report to their offering. The analysts forecast the Global Hematology Analyzers market to grow at a CAGR of 3.59 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increasing aging population. The Global Hematology Analyzers market has also been witnessing the consolidation of the Industrial sector. However, the high cost of hematology analyzers could pose a challenge to the growth of this market. The key vendors dominating this market space are Abbott Diagnostics Inc., Becton Dickinson & Co., Danaher Corp., and Sysmex Corp. Other vendors mentioned in the report are Dade Behring Inc, Diagnostica Stago SAS, Roche Diagnostics AG, and Siemens Healthcare Diagnostics Inc. Commenting on the report, an analyst from the team said: Manufacturers in this market continue to introduce instruments designed to ease the labor shortage's effects on laboratories. Top vendors in this market followed a strategy to provide rapid and accurate clinical information to the clinician that requires little or no additional technical intervention. For instance, Sysmex Corp. launched XE-5000 hematology analyzer equipped with an improved body fluid analysis mode. Similarly, the launch of Coulter LH 780 hematology series by Beckman Coulter Inc. was a new addition to the product offered in the market. This increasing demand for automated alternatives is influencing the growth of analyzers, and is shifting manufacturers focus toward automation. According to the report, one of the main drivers in is the increasing aging population worldwide. An increase in the aging population means a substantial increase in the incidence of many age-related diseases. People aged 60 and above are more prone to chronic diseases and require access to medical therapies requiring laboratory testing. Hematology analyzers offer great hope for the early detection of these and other diseases. For more information visit http://www.researchandmarkets.com/research/lf8chh/global_hematology About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Global In-Vitro Diagnostic (IVD) Market Report 2013-2017
M2 - Mon Oct 14, 10:01AM CDT
Research and Markets (http://www.researchandmarkets.com/research/gp4tlh/in_vitro) has announced the addition of the Global In-Vitro Diagnostic (IVD) Market Report 2013-2017 report to their offering. The global in vitro diagnostic market was valued at $49.2 billion in 2012 and is expected to reach $69.1 billion by 2017, at a CAGR of 7% from 2012 to 2017. The in vitro diagnostic market studied in this report has been segmented by technology, product type, application, end user, and geography. The technology market is further segmented into clinical chemistry, immunochemistry, molecular diagnostics, hematology, coagulation, microbiology, and others, of which immunochemistry accounted for the largest share with 25.8% in 2010. By product type, the IVD market has segments like instruments, reagents, data management software/hardware, and services. Based on applications, the in vitro diagnostic market is segmented as diabetes, infectious diseases, oncology, cardiology, nephrology, auto-immune diseases, AIDS, drug testing, and others. Laboratory testing, hospital testing, academic (AMCs and university) testing, point-of-care testing, patient self-testing, and others comprise the end-user segment of the IVD market. The IVD market is primarily driven by rising incidences of chronic and infectious diseases in emerging economies, a rapidly aging population, the rise in point-of-care testing, and the rising importance of personalized medicine. However, factors such as stringent regulatory frameworks and a shortage of budget and labor are restraining the growth of the market. In 2012, the Americas had accounted for the largest share of the global in vitro diagnostic market, followed by Europe. However, the BRIC countries represent the fastest-growing markets due to the economic growth, the rising number of chronic diseases, and an increasing awareness about the use of in vitro disgnostic tests to control the spread of diseases. Moreover, the economic slowdown, pricing pressures, and high competition in mature countries will compel companies to focus on emerging markets. Technique: - Immunochemistry - Clinical Chemistry - Molecular Diagnostics - Hematology - Microbiology - Coagulation - Other Clinical Instruments (clinical centrifuges, sample processers, washers, histology, cytology, and flow cytometry) Product Type: - Reagents - Instruments - Services - Data Management System Software/Hardware Application: - Diabetes - Infectious Diseases - Oncology - Cardiology - HIV/AIDS - Autoimmune Diseases - Drug Testing - Nephrology - Others (endocrine tests, blood analysis tests, pregnancy tests, and general clinical applications) End-Users: - Hospitals - Laboratories - Patient Self-testing - POCT (Point-of-Care Testing) - Academics - Others (blood banks, local public health laboratories, community clinics, home health agencies, nursing homes, and ambulatory surgical centers) Key Topics Covered: 1 Introduction 2 Executive Summary 3 Market Overview 4 Global In Vitro Diagnostic Market, By Technique 5 Global In Vitro Diagnostic Market, By Product Type 6 Global In Vitro Diagnostic Market, By Application 7 Global In Vitro Diagnostic Market, By End-User 8 Geographic Analysis 9 Competitive Landscape 10 Company Profiles - Overview, Financials, Products & Services, Developments & Strategy - Abbott Laboratories, Inc - Alere, Inc - Arkray, Inc - Bayer AG - Becton, Dickinson And Company - Bio-Rad Laboratories, Inc - Biomerieux - Danaher Corporation - Diagnostica Stago Sas - Diasorin SPA - Hologic, Inc - Horiba, Ltd - Johnson & Johnson - Novartis International Ag - Qiagen NV - Roche Diagnostics Limited - Siemens Healthcare - Sysmex Corporation - Thermo Fisher Scientific, Inc For more information visit http://www.researchandmarkets.com/research/gp4tlh/in_vitro
Sysmex Inostics and Bayer HealthCare Collaborate to Develop Blood-based Companion Diagnostic Tests for Targeted Tumor Therapies
PR Newswire Europe - Wed Oct 09, 1:02AM CDT
HAMBURG, Germany, October 9, 2013 /PRNewswire/ --
Cell Surface Markers Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast 2012 - 2018
M2 - Fri Sep 13, 9:31AM CDT
Research and Markets (http://www.researchandmarkets.com/research/dbxpsd/cell_surface) has announced the addition of the "Cell Surface Markers Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast 2012 - 2018" report to their offering. 'Cell Surface Markers (Flow Cytometers, Hematology Analyzers, Reagents And Kits) Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2012 - 2018' The cell surface markers market is undergoing impressive growth across the globe due to rapid automation of technologies and solutions, simplification of data management, and the increasing preference for reduction of healthcare spending with a view to provide rapid and efficient decision making for therapies for specific diseases. As well as this the high prevalence of chronic diseases such as cancer and autoimmune disorders has resulted in an elevated demand for cell surface markers analysis worldwide. Since their introduction, the study of cell surface makers has undergone tremendous technological development. It is expected that soon end-users will be benefiting from the increasing scope of applications of cell surface markers. This report studies the cell surface markers market by the types of products commercially available for cell markers analysis. Each segment has been analyzed on the basis of its current and future market size for the period 2011 to 2019, in terms of revenue generation in USD million. The CAGR (%) of all segments has been provided for the forecast period of 2013 to 2019, considering 2012 as the base year. In terms of geography, this market has been classified into North America, Europe, Asia-Pacific and Rest of the World (RoW) regions. The respective market size for each region and their forecast till 2019 has also been presented in the report. In addition, a qualitative assessment of the market dynamics of the cell surface markers market has been provided, wherein the drivers, restraints, opportunities and market attractiveness has been studied. The competitive landscape section of this report provides a bird's eye view of the major market players currently operating in this market and their respective products. Also, a pipeline snapshot of new entrants in this market along with their development stage products has been included. Key Topics Covered: Chapter 1 Introduction Chapter 2 Executive Summary Chapter 3 Market Overview Chapter 4 Global Cell Surface Markers Market, by Instruments and Reagents Chapter 5 Global Cell Surface Markers Market, by Applications Chapter 6 Global Cell Surface Markers Market, by Geography Chapter 7 Recommendations Chapter 8 Company Profiles List of Figure List of Table Companies Mentioned - Abbott Laboratories, Inc - BD Biosciences - Beckman Coulter, Inc - Bio-Rad Laboratories, Inc - F Hoffmann-La Roche Ltd - Grifols SA - Immucor, Inc - Janssen Diagnostics, Inc - Nihon Kohden Corporation - Siemens Healthcare - Sysmex Corporation - Thermo Fischer Scientific, Inc For more information visit http://www.researchandmarkets.com/research/dbxpsd/cell_surface About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
In Vitro Diagnostic (IVD) Market, Technique & Applications - Forecast To 2017
M2 - Wed Aug 07, 6:40AM CDT
Research and Markets (http://www.researchandmarkets.com/research/wnvq5b/in_vitro) has announced the addition of the "In Vitro Diagnostic (IVD) Market, Technique & Applications - Forecast To 2017" report to their offering. The global in vitro diagnostics market was valued at $49.2 billion in 2012. The factors likely to fuel the growth of the market include on-going developments in analytical laboratory automation, swift progress in various fields of diagnosis such as point-of-care testing, molecular diagnosis, immunoassays, hematology, flow cytometry, microbiology and finally, the geographical market expansion within emerging countries. The most important trend witnessed recently in the in vitro diagnostic industry is that of self-testing as opposed to patients visiting hospitals. This is one of the biggest factors responsible for the growth of point-of-care testing, as patients prefer self-testing to avoid unnecessary visits to the hospital. However, factors such as stringent regulatory frameworks and a shortage of budget are restraining the growth of this market. Key Topics Covered: 1 Introduction 2 Executive Summary 3 Market Overview 4 Global In Vitro Diagnostic Market, By Technique 5 Global In Vitro Diagnostic Market, By Product Type 5.1 Introduction 5.2 Instruments 5.3 Reagents 5.4 Data Management System Software/Hardware 5.5 Services 6 Global In Vitro Diagnostic Market, By Application 6.1 Introduction 6.2 Diabetes 6.3 Infectious Diseases 6.4 Oncology/Cancer 6.5 Cardiology 6.6 Nephrology 6.7 Autoimmune Diseases 6.8 Drug Testing 6.9 HIV/Aids 6.10 Others 7 Global In Vitro Diagnostic Market, By End-User 7.1 Introduction 7.2 Laboratory 7.3 Hospitals 7.4 Academics 7.5 Point-Of-Care Testing 7.6 Patient Self-Testing 7.7 Others 8 Geographic Analysis 9 Competitive Landscape 10 Company Profiles (Overview, Financials, Products & Services, Developments & Strategy)* Companies Mentioned - Abbott Laboratories, Inc - Alere, Inc - Arkray, Inc - Bayer AG - Becton, Dickinson And Company - Bio-Rad Laboratories, Inc - Biomerieux - Danaher Corporation - Diagnostica Stago Sas - Diasorin SPA - Hologic, Inc - Horiba, Ltd - Johnson & Johnson - Novartis International Ag - Qiagen NV - Roche Diagnostics Limited - Siemens Healthcare - Sysmex Corporation - Thermo Fisher Scientific, Inc For more information visit http://www.researchandmarkets.com/research/wnvq5b/in_vitro
Switzerland In Vitro Diagnostics Report complete with information on company financials and pipeline products
M2 - Mon Jul 01, 3:50AM CDT
Research and Markets (http://www.researchandmarkets.com/research/jvbk4h/switzerland_in) has announced the addition of the "Switzerland In Vitro Diagnostics Investment Opportunities, Analysis and Forecasts to 2018" report to their offering. Switzerland In Vitro Diagnostics Investment Opportunities, Analysis and Forecasts to 2018 provides key market data on the Switzerland In Vitro Diagnostics market. The report provides value (USD) million data for each segment and sub-segment within seven market categories - Immuno Chemistry, Clinical Chemistry, Haematology, Infectious Immunology, Microbiology Culture, Histology And Cytology and Genetic Testing. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants with information on company financials and pipeline products, wherever available. Scope - Market size and company share data for In Vitro Diagnostics
Sysmex Renews Agreement to Distribute EasyCell assistant Hematology Imaging System from Medica
PR Newswire - Fri Jun 28, 9:13AM CDT
Sysmex America Inc., the wholly owned U.S. subsidiary of Sysmex Corporation, has announced they have renewed their agreement with Medica Corporation to distribute Medica's EasyCell® assistant for digital cell image analysis in hematology laboratories.
Concise Analysis of the International In Vitro Diagnostic (IVD) Market - Forecast To 2017
M2 - Tue Mar 11, 6:07AM CDT
Research and Markets (http://www.researchandmarkets.com/research/nc4zfn/in_vitro) has announced the addition of the "Concise Analysis of the International In Vitro Diagnostic (IVD) Market - Forecast To 2017" report to their offering. The in vitro diagnostic market studied in this report has been segmented by technology, product type, application, end user, and geography. The technology market is further segmented into clinical chemistry, immunochemistry, molecular diagnostics, hematology, coagulation, microbiology, and others, of which immunochemistry accounted for the largest share with 25.8% in 2010. By product type, the IVD market has segments like instruments, reagents, data management software/hardware, and services. Based on applications, the in vitro diagnostic market is segmented as diabetes, infectious diseases, oncology, cardiology, nephrology, auto-immune diseases, AIDS, drug testing, and others. Laboratory testing, hospital testing, academic (AMCs and university) testing, point-of-care testing, patient self-testing, and others comprise the end-user segment of the IVD market. The global in vitro diagnostic market was valued at $49.2 billion in 2012 and is expected to reach $69.1 billion by 2017, at a CAGR of 7% from 2012 to 2017. The IVD market is primarily driven by rising incidences of chronic and infectious diseases in emerging economies, a rapidly aging population, the rise in point-of-care testing, and the rising importance of personalized medicine. However, factors such as stringent regulatory frameworks and a shortage of budget and labor are restraining the growth of the market. Key Topics Covered: 1 Introduction 2 Executive Summary 3 Market Overview 4 Global In Vitro Diagnostic Market, By Technique 5 Global In Vitro Diagnostic Market, By Product Type 6 Global In Vitro Diagnostic Market, By Application 7 Global In Vitro Diagnostic Market, By End-User 8 Geographic Analysis 9 Competitive Landscape 10 Company Profiles Companies Mentioned: - Abbott Laboratories, Inc - Alere, Inc - Arkray, Inc - Bayer AG - Becton, Dickinson And Company - Bio-Rad Laboratories, Inc - Biomerieux - Danaher Corporation - Diagnostica Stago Sas - Diasorin SPA - Hologic, Inc - Horiba, Ltd - Johnson & Johnson - Novartis International Ag - Qiagen NV - Roche Diagnostics Limited - Siemens Healthcare - Sysmex Corporation - Thermo Fisher Scientific, Inc For more information visit http://www.researchandmarkets.com/research/nc4zfn/in_vitro
Global Endocrine Testing Market to 2019: E2, FSH, hCG, LH, DHEAS, Progesterone, Testosterone, TSH, Prolactin, Cortisol, Insulin Tests
M2 - Wed Feb 26, 9:04AM CST
Research and Markets (http://www.researchandmarkets.com/research/bk2st3/endocrine_testing) has announced the addition of the "Global Endocrine Testing Market to 2019: E2, FSH, hCG, LH, DHEAS, Progesterone, Testosterone, TSH, Prolactin, Cortisol, Insulin Tests" report to their offering. Endocrinology, a branch of medicine deals with the study of structural and functional elements of the endocrine system. This system comprises endocrine glands (thyroid, adrenal, pituitary and others) and secretory organs (pancreas, hypothalamus) that release hormones directly into the blood stream and regulate the body functioning. Endocrine testing market is studied by three major segments namely, by test, by diagnostic technologies and by end users. The test segment is further classified into 11 major hormone tests that includes estradiol (E2), Follicle Stimulating Hormone (FSH), Human Chorionic Gonadotropin (hCG), Luteinizing hormone (LH), Dehydroepiandrosterone sulfate (DHEAS), progesterone, testosterone, Thyroid Stimulating Hormone (TSH), prolactin, cortisol and insulin tests. The market accounts for a wide range of conventional as well as rapid diagnostic kits used for detecting deficiency (hyposecretion) or excess (hypersecretion) secretions of these hormones. The diagnostic technologies segment further describes the technological platforms used in the analysis of the specimen test sample (blood, urine, etc) and is further categorized into five major technologies, tandem mass spectrometry, immunoassay, monoclonal and polyclonal antibody, sensor and clinical chemistry technologies. The end user segment elucidates the endocrine testing market by various end users that includes hospitals, commercial laboratories, ambulatory health care centers, home based tests and physician's offices. The global endocrine testing market is segmented into the following categories: Tests - Estradiol (E2) Test - Follicle Stimulating Hormone (FSH) Test - Human Chorionic Gonadotropin (hCG) Test - Luteinizing Hormone (LH) Test - Dehydroepiandrosterone sulfate (DHEAS) Test - Progesterone Test - Testosterone Test - Thyroid Stimulating Hormone (TSH) Test - Prolactin Test - Cortisol Test - Insulin Test - Others (Gastrin, Thymosin, Secretin, etc.) Diagnostic Technologies - Tandem Mass spectrometry - Immunoassay (Enzyme immunoassays, Radioimmunoassays (RIA)) Technologies - Monoclonal and Polyclonal Antibody Technologies - Sensor (Electrochemical, Biosensors, etc.) Technologies - Clinical Chemistry Technologies - Others (Liquid Chromatography Mass Spectrometry (LC-MS), High performance Liquid Chromatography (HPLC), etc.) Location - Hospitals - Commercial Laboratories - Ambulatory Care Centers - Home Based Tests - Physician Offices Key Topics Covered: Chapter 1 Preface Chapter 2 Executive Summary Chapter 3 Market Overview Chapter 4 Endocrine Testing Market, by Test Chapter 5 Endocrine Testing Market, by Diagnostic Technologies Chapter 6 Endocrine Testing Market, by End Users Chapter 7 Endocrine Testing Market, by Geography Chapter 8 Competitive Landscape Chapter 9 Recommendations Chapter 10 Company Profiles Companies Mentioned - Abbott Laboratories - AB SCIEX LLC - Agilent Technologies - Biomedical Diagnostics - bioMerieux - Bio-Rad Laboratories, Inc. - DiaSorin S.p.A - F. Hoffmann-La Roche Ltd. - Laboratory Corporation of America Holdings (LabCorp) - Ortho Clinical Diagnostics - Quest Diagnostics - Siemens Healthcare - Sysmex Corporation - Thermo Fisher Scientific For more information visit http://www.researchandmarkets.com/research/bk2st3/endocrine_testing
Concise Analysis of the International Pico Projectors Market - Forecasts to 2016
M2 - Tue Feb 04, 3:23AM CST
Research and Markets (http://www.researchandmarkets.com/research/vjgw5g/global_pico) has announced the addition of the "Concise Analysis of the International Pico Projectors Market - Forecasts to 2016" report to their offering. Analysts forecast the Global Pico Projectors market to grow at a CAGR of 32.7 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increasing integration of pico projectors in mobile handsets. The Global Pico Projectors market has also been witnessing increasing adoption of embedded pico projectors. However, limited features in pico projectors could pose a challenge to the growth of this market. "Concise Analysis of the International Pico Projectors Market - Forecasts to 2016", has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market in the Americas, the EMEA, and the APAC regions; it also covers the Global Pico Projectors market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market. The key vendors dominating this market space include 3M Co., MicroVision Inc., Optoma Corp., Syndiant Inc., and Texas Instruments Inc. The other vendors mentioned in this report are AAXA Technologies Inc., Acer Inc., Aiptek Inc., bTendo Ltd., Greenlight Optics LLC., Lemoptix SA., Light Blue Optics Ltd., Luminus Device Inc., Maradin Ltd., Mezmeriz Inc., Micron Technology Inc., Opus Microsystems Corp., Samsung Electronics Co. Ltd., Toshiba Corp., and WowWee Group Ltd. Key Topics Covered: 1. Executive Summary 2. List of Abbreviations 3. Introduction 4. Research Methodology 5. Scope of the Report 6. Market Landscape 7. Geographical Segmentation 8. Vendor Landscape 9. Buying Criteria 10. Market Growth Drivers 11. Drivers and their Impact 12. Market Challenges 13. Impact of Drivers and Challenges 14. Market Trends 15. Key Vendor Analysis 16. Other Reports in this Series Companies Mentioned: - 3M - AAXA Technologies. - Acer - Aiptek - Greenlight Optics - Lemoptix - Light Blue Optics - Luminus Device - Maradin - Mezmeriz - MicroVision - Micron Technology - Optoma - Opus Microsystems - Samsung Electronics - Syndiant - Texas Instruments - Toshiba - WowWee Group - bTendo For more information visit http://www.researchandmarkets.com/research/vjgw5g/global_pico
Black Alliance for Educational Options Applauds the Center for Education Reform for Insightful Report on Charter Schools
Marketwire - Thu Jan 30, 1:41PM CST
The Black Alliance for Educational Options (BAEO) applauds the Center for Education Reform (CER) for the release of their Survey of America's Charter Schools. The 23-page report provides an in-depth analysis of charter school students, operations, and teachers, and discusses trends over time in the Size and Scope, Demographics, Finance and Operations, and Academic Program of charter schools and insights into why demand for these independent schools has grown.
2013 Report on the International Cell Surface Markers Market - Trends and Forecasts to 2018
M2 - Fri Jan 24, 6:24AM CST
Research and Markets (http://www.researchandmarkets.com/research/ccmnwh/cell_surface) has announced the addition of the "2013 Report on the International Cell Surface Markers Market - Trends and Forecasts to 2018" report to their offering. Cell surface markers serve as the prime component in identification and categorization of cells such as lymphocytes, macrophages, monocytes, tumor cells and other cells majorly related to immunology. Cell surface marker analysis is performed through the use of technologies namely, flow cytometry and hematology analyzers and can be carried out on various samples such as lymph nodes, blood, bone marrow and other tissues. Such analysis may allow simplification of disease diagnosis and identification, sample preparation and drug discovery. Identification of specific types of molecules through cell surface marker analysis helps in efficient disease diagnosis and thereby assists in determination of disease treatment and drugs. Cell surface markers analysis enables the quantification of the scope of new drugs reaching the intended target and are also responsible for achieving the clinical outcomes by altering the proposed pathophysiological mechanisms. Disease diagnosis by detection or use of cell surface markers has been beneficial and critical in developing innovative and reliable indicators with high specificity for the diagnosis and prognosis of different types of diseases, majorly cancer. Companies investing heavily in developing automated systems with improved sample processing and analysis may gain greater benefits in the near future. Introduction of new and cost-effective instruments is further facilitating the growth of new market entrants and is also being achieved via showcasing advantages of the software and technical capabilities of their instruments at various conferences, laboratories, trade shows, web casting and electronic newsletters. Key Topics Covered: 1 Introduction 2 Executive Summary 3 Market Overview 4 Global Cell Surface Markers Market, by Instruments and Reagents 5 Global Cell Surface Markers Market, by Applications 6 Global Cell Surface Markers Market, by Geography 7 Recommendations 8 Company Profiles Companies Mentioned: - Abbott Laboratories - BD Biosciences - Beckman Coulter - Bio-Rad Laboratories - F Hoffmann-La Roche - Grifols - Immucor - Janssen Diagnostics - Nihon Kohden Corporation - Siemens Healthcare - Sysmex Corporation - Thermo Fischer Scientific For more information visit http://www.researchandmarkets.com/research/ccmnwh/cell_surface
Do You Know How to Read a Report Card?
by Charles Ekyagonza - All Africa Global Media - Fri Jan 17, 1:44AM CST
At the end of every term, learners are given report cards as a way of evaluating their work and behaviour during the term.
Akingbola Challenges Lagos Court's Jurisdiction to Register London Judgment Against Him
by Davidson Iriekpen - All Africa Global Media - Fri Jan 17, 1:37AM CST
A former Managing Director of the defunct Intercontinental Bank Plc., Mr. Erastus Akingbola, has challenged the jurisdiction of a Lagos High Court to register a GBP654 million judgment delivered against him by a London court.
Kwadaso MP Embarks On Road Maintenance Program
All Africa Global Media - Thu Jan 16, 12:02PM CST
From Issah Alhassan, Kumasi THE MEMBER of Parliament for the Kwadaso Constituency, Dr. Owusu Afriyie Akoto, has launched a community infrastructural initiative programme aimed at addressing the overwhelming road infrastructure challenges confronting commuters and drivers in the constituency.
Brendan Ives has been appointed as a new President of TeliaSonera International Carrier. (TSIC)
M2 - Tue Jan 14, 8:52AM CST
Originally from New Zealand, Brendan has been working in key roles at TSIC since 2001.
Global Immunoassay Market Report - World Forecasts to 2018
M2 - Mon Jan 06, 4:09AM CST
Research and Markets (http://www.researchandmarkets.com/research/88b6j7/immunoassay) has announced the addition of the "Global Immunoassay Market Report - World Forecasts to 2018" report to their offering. Immunoassay has evolved as an integral part of the modern medical care practice owing to the continuous technological advancements in this field, the increase in healthcare awareness among people, and the increasing use of immunoassay tests in diagnosis and monitoring. This research report categorizes the global on the basis of technology, application, product (analyzers and reagents), and end users. On the basis of technology, the enzyme immunoassay segment accounted for the largest share of the global market in 2012. Long-term presence in the market, high sensitivity for infectious/viral disease testing, and the huge demand from developing countries due to the lower costs of enzyme immunoassay in comparison to chemiluminescence immunoassay (CLIA) are all factors that are responsible for its growing share in the market. On the basis of product, the reagents market accounted for the largest share of this market in 2012. The accessibility of a wide range of reagents and the need for reliable, specific, and faster detection of chronic diseases at early stages are factors that are expected to drive the immunoassay reagents market. Key Topics Covered: 1 Introduction 2 Executive Summary 3 Premium Insights 4 Industry Analysis & Market Overview 5 Immunoassay Market, By Technology 6 Immunoassay Market, By Products (Analyzers & Reagents) 7 Immunoassay Market, By Application 8 Global Immunoassay Market, By End-Users 9 Geographic Analysis 10 Competitive Landscape 11 Company Profiles Companies Mentioned: - Abbott Laboratories, Inc - Alere, Inc - Becton, Dickinson And Company - Biom?rieux - DRG International, Inc - Danaher Corporation (Beckman Coulter) - Diasorin SPA - Diasource Immunoassays SA - Hologic (Gen-Probe ) - IBL International GMBH - IDS Plc - Meridian Life Science, Inc - Ortho Clinical Diagnostics (A J&J Company) - Qiagen NV - Roche Diagnostics Limited - Siemens Healthcare - Sysmex Corporation - Thermo Fisher Scientific, Inc (Brahms) For more information visit http://www.researchandmarkets.com/research/88b6j7/immunoassay
2013 Report on the International In Vitro Diagnostic (IVD) Market - Includes Forecast To 2017
M2 - Fri Jan 03, 5:34AM CST
Research and Markets (http://www.researchandmarkets.com/research/wxrj4l/in_vitro) has announced the addition of the "2013 Report on the International In Vitro Diagnostic (IVD) Market - Includes Forecast To 2017" report to their offering. In 2012, the Americas had accounted for the largest share of the global in vitro diagnostic market, followed by Europe. However, the BRIC countries represent the fastest-growing markets due to the economic growth, the rising number of chronic diseases, and an increasing awareness about the use of IVD tests to control the spread of diseases. Moreover, the economic slowdown, pricing pressures, and high competition in mature countries will compel companies to focus on emerging markets. This research report categorizes the global IVD (In vitro diagnostic) market on the basis of technique, product type, application, and end-users. These markets are broken down into segments and sub-segments, providing exhaustive value analysis for 2010, 2011 and 2012, as well as forecast up to 2017. Each of the devices market is comprehensively analyzed at a granular level by geography (North America, Europe, BRIC, Japan and Rest of the World) to provide in-depth information on the global scenario. These regions are further analyzed at major country levels. The key players are Abbott Laboratories, Inc. (U.S.), Roche Diagnostics Limited (Switzerland), Becton, Dickson and Company (U.S.), Siemens Healthcare (Germany), Diagnostica Stago SAS (France), Danaher Corporation (U.S.), Thermo Fisher Scientific, Inc. (U.S.), ARKRAY, Inc. (Japan), Bio-Rad Laboratories, Inc. (U.S.), DiaSorin S.p.A. (Italy), Sysmex Corporation (Japan), bioM?rieux (France), HORIBA, Ltd. (Japan), and Alere, Inc. (U.S.). Key Topics Covered: 1 Introduction 2 Executive Summary 3 Market Overview 4 Global In Vitro Diagnostic Market, By Technique 5 Global In Vitro Diagnostic Market, By Product Type 6 Global In Vitro Diagnostic Market, By Application 7 Global In Vitro Diagnostic Market, By End-User 8 Geographic Analysis 9 Competitive Landscape 10 Company Profiles Companies Mentioned: - Abbott Laboratories - Alere - Arkray - Bayer - Becton, Dickinson And Company - Bio-Rad Laboratories - Biomerieux - Danaher Corporation - Diagnostica Stago - Diasorin SPA - Hologic - Horiba - Johnson & Johnson - Novartis International - Qiagen NV - Roche Diagnostics Limited - Siemens Healthcare - Sysmex Corporation - Thermo Fisher Scientific For more information visit http://www.researchandmarkets.com/research/wxrj4l/in_vitro
Global Cell Surface Markers Market to 2018: Flow Cytometers, Hematology Analyzers, Reagents And Kits
M2 - Thu Nov 28, 10:25AM CST
Research and Markets (http://www.researchandmarkets.com/research/b2t35p/cell_surface) has announced the addition of the "Global Cell Surface Markers Market to 2018: Flow Cytometers, Hematology Analyzers, Reagents And Kits" report to their offering. Cell surface markers are unique to cell types and have vital functional role in immunology. These are generally antigens or molecules present within the plasma membrane of the cell. Such markers serve as the prime component in identification and categorization of cells such as lymphocytes, macrophages, monocytes, tumor cells and other cells majorly related to immunology. Cell surface marker analysis is performed through the use of technologies namely, flow cytometry and hematology analyzers and can be carried out on various samples such as lymph nodes, blood, bone marrow and other tissues. Such analysis may allow simplification of disease diagnosis and identification, sample preparation and drug discovery. Identification of specific types of molecules through cell surface marker analysis helps in efficient disease diagnosis and thereby assists in determination of disease treatment and drugs. Cell surface markers analysis enables the quantification of the scope of new drugs reaching the intended target and are also responsible for achieving the clinical outcomes by altering the proposed pathophysiological mechanisms. Disease diagnosis by detection or use of cell surface markers has been beneficial and critical in developing innovative and reliable indicators with high specificity for the diagnosis and prognosis of different types of diseases, majorly cancer. High-throughput tools and techniques in addition to miniature and robust instruments with manifold applications have been the recent need to meet requirements of both research and clinical sectors. Companies investing heavily in developing automated systems with improved sample processing and analysis may gain greater benefits in the near future. Introduction of new and cost-effective instruments is further facilitating the growth of new market entrants and is also being achieved via showcasing advantages of the software and technical capabilities of their instruments at various conferences, laboratories, trade shows, web casting and electronic newsletters. At present, a broad range of assay technologies and solutions for cell surface marker research are available in the market to enable the analysis of gene expression and regulation, genotyping, signal transduction and epigenetic modifications. Some of the most common solutions available for cell surface marker analysis are PCR array, miRNA, pathway reporter, mutation analysis, DNA methylation and protein expression. Complexity of high-end flow cytometers and expensive reagents, controls and analysis systems results into lowering the adoption of sophisticated cell marker analysis solutions, particularly in economically lagged countries. Thus rising preference for lowering healthcare spending by cost containment in diagnosis procedures coupled with rapid and efficient decision making for therapies of specific diseases will further aid in sustaining the growing acceptance of cell surface marker analysis worldwide. Geographically, North America dominates the global cell surface markers market. As majority of the prime players in the market are domiciled in North America, many technological advancements first are introduced in this region. Growing acceptance of cell surface markers analysis by major industries and verified efficiency in clinical laboratories drives the market for cell surface markers in North America. In addition, factors such as increased market consolidation, simplification of analysis process, cost containment of instruments and reagents and introduction of cheaper products will result in rapid adoption of research in cell surface markers field in the emerging markets. Furthermore, increase in healthcare awareness, affordability, better patient rehabilitation, growth in medical tourism and less competition levels than developed markets will result in growth in demand for identification of cell surface markers and associated disease diagnosis and treatment in emerging economies. Key Topics Covered: Chapter 1 Introduction Chapter 2 Executive Summary Chapter 3 Market Overview Chapter 4 Global Cell Surface Markers Market, by Instruments and Reagents Chapter 5 Global Cell Surface Markers Market, by Applications Chapter 6 Global Cell Surface Markers Market, by Geography Chapter 7 Recommendations Chapter 8 Company Profiles - Abbott Laboratories, Inc - BD Biosciences - Beckman Coulter, Inc - Bio-Rad Laboratories, Inc - F Hoffmann-La Roche Ltd - Grifols SA - Immucor, Inc - Janssen Diagnostics, Inc - Nihon Kohden Corporation - Siemens Healthcare - Sysmex Corporation - Thermo Fischer Scientific, Inc For more information visit http://www.researchandmarkets.com/research/b2t35p/cell_surface
Global Hematology Analyzers Market 2012-2016: Featuring Top Sellers such as Sysmex Corp and Becton Dickinson & Co.
M2 - Wed Nov 27, 11:17AM CST
Research and Markets (http://www.researchandmarkets.com/research/lf8chh/global_hematology) has announced the addition of the "Global Hematology Analyzers Market 2012-2016" report to their offering. The analysts forecast the Global Hematology Analyzers market to grow at a CAGR of 3.59 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increasing aging population. The Global Hematology Analyzers market has also been witnessing the consolidation of the Industrial sector. However, the high cost of hematology analyzers could pose a challenge to the growth of this market. The key vendors dominating this market space are Abbott Diagnostics Inc., Becton Dickinson & Co., Danaher Corp., and Sysmex Corp. Other vendors mentioned in the report are Dade Behring Inc, Diagnostica Stago SAS, Roche Diagnostics AG, and Siemens Healthcare Diagnostics Inc. Commenting on the report, an analyst from the team said: Manufacturers in this market continue to introduce instruments designed to ease the labor shortage's effects on laboratories. Top vendors in this market followed a strategy to provide rapid and accurate clinical information to the clinician that requires little or no additional technical intervention. For instance, Sysmex Corp. launched XE-5000 hematology analyzer equipped with an improved body fluid analysis mode. Similarly, the launch of Coulter LH 780 hematology series by Beckman Coulter Inc. was a new addition to the product offered in the market. This increasing demand for automated alternatives is influencing the growth of analyzers, and is shifting manufacturers focus toward automation. According to the report, one of the main drivers in is the increasing aging population worldwide. An increase in the aging population means a substantial increase in the incidence of many age-related diseases. People aged 60 and above are more prone to chronic diseases and require access to medical therapies requiring laboratory testing. Hematology analyzers offer great hope for the early detection of these and other diseases. For more information visit http://www.researchandmarkets.com/research/lf8chh/global_hematology About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Global In-Vitro Diagnostic (IVD) Market Report 2013-2017
M2 - Mon Oct 14, 10:01AM CDT
Research and Markets (http://www.researchandmarkets.com/research/gp4tlh/in_vitro) has announced the addition of the Global In-Vitro Diagnostic (IVD) Market Report 2013-2017 report to their offering. The global in vitro diagnostic market was valued at $49.2 billion in 2012 and is expected to reach $69.1 billion by 2017, at a CAGR of 7% from 2012 to 2017. The in vitro diagnostic market studied in this report has been segmented by technology, product type, application, end user, and geography. The technology market is further segmented into clinical chemistry, immunochemistry, molecular diagnostics, hematology, coagulation, microbiology, and others, of which immunochemistry accounted for the largest share with 25.8% in 2010. By product type, the IVD market has segments like instruments, reagents, data management software/hardware, and services. Based on applications, the in vitro diagnostic market is segmented as diabetes, infectious diseases, oncology, cardiology, nephrology, auto-immune diseases, AIDS, drug testing, and others. Laboratory testing, hospital testing, academic (AMCs and university) testing, point-of-care testing, patient self-testing, and others comprise the end-user segment of the IVD market. The IVD market is primarily driven by rising incidences of chronic and infectious diseases in emerging economies, a rapidly aging population, the rise in point-of-care testing, and the rising importance of personalized medicine. However, factors such as stringent regulatory frameworks and a shortage of budget and labor are restraining the growth of the market. In 2012, the Americas had accounted for the largest share of the global in vitro diagnostic market, followed by Europe. However, the BRIC countries represent the fastest-growing markets due to the economic growth, the rising number of chronic diseases, and an increasing awareness about the use of in vitro disgnostic tests to control the spread of diseases. Moreover, the economic slowdown, pricing pressures, and high competition in mature countries will compel companies to focus on emerging markets. Technique: - Immunochemistry - Clinical Chemistry - Molecular Diagnostics - Hematology - Microbiology - Coagulation - Other Clinical Instruments (clinical centrifuges, sample processers, washers, histology, cytology, and flow cytometry) Product Type: - Reagents - Instruments - Services - Data Management System Software/Hardware Application: - Diabetes - Infectious Diseases - Oncology - Cardiology - HIV/AIDS - Autoimmune Diseases - Drug Testing - Nephrology - Others (endocrine tests, blood analysis tests, pregnancy tests, and general clinical applications) End-Users: - Hospitals - Laboratories - Patient Self-testing - POCT (Point-of-Care Testing) - Academics - Others (blood banks, local public health laboratories, community clinics, home health agencies, nursing homes, and ambulatory surgical centers) Key Topics Covered: 1 Introduction 2 Executive Summary 3 Market Overview 4 Global In Vitro Diagnostic Market, By Technique 5 Global In Vitro Diagnostic Market, By Product Type 6 Global In Vitro Diagnostic Market, By Application 7 Global In Vitro Diagnostic Market, By End-User 8 Geographic Analysis 9 Competitive Landscape 10 Company Profiles - Overview, Financials, Products & Services, Developments & Strategy - Abbott Laboratories, Inc - Alere, Inc - Arkray, Inc - Bayer AG - Becton, Dickinson And Company - Bio-Rad Laboratories, Inc - Biomerieux - Danaher Corporation - Diagnostica Stago Sas - Diasorin SPA - Hologic, Inc - Horiba, Ltd - Johnson & Johnson - Novartis International Ag - Qiagen NV - Roche Diagnostics Limited - Siemens Healthcare - Sysmex Corporation - Thermo Fisher Scientific, Inc For more information visit http://www.researchandmarkets.com/research/gp4tlh/in_vitro
Sysmex Inostics and Bayer HealthCare Collaborate to Develop Blood-based Companion Diagnostic Tests for Targeted Tumor Therapies
PR Newswire Europe - Wed Oct 09, 1:02AM CDT
HAMBURG, Germany, October 9, 2013 /PRNewswire/ --
Cell Surface Markers Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast 2012 - 2018
M2 - Fri Sep 13, 9:31AM CDT
Research and Markets (http://www.researchandmarkets.com/research/dbxpsd/cell_surface) has announced the addition of the "Cell Surface Markers Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast 2012 - 2018" report to their offering. 'Cell Surface Markers (Flow Cytometers, Hematology Analyzers, Reagents And Kits) Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2012 - 2018' The cell surface markers market is undergoing impressive growth across the globe due to rapid automation of technologies and solutions, simplification of data management, and the increasing preference for reduction of healthcare spending with a view to provide rapid and efficient decision making for therapies for specific diseases. As well as this the high prevalence of chronic diseases such as cancer and autoimmune disorders has resulted in an elevated demand for cell surface markers analysis worldwide. Since their introduction, the study of cell surface makers has undergone tremendous technological development. It is expected that soon end-users will be benefiting from the increasing scope of applications of cell surface markers. This report studies the cell surface markers market by the types of products commercially available for cell markers analysis. Each segment has been analyzed on the basis of its current and future market size for the period 2011 to 2019, in terms of revenue generation in USD million. The CAGR (%) of all segments has been provided for the forecast period of 2013 to 2019, considering 2012 as the base year. In terms of geography, this market has been classified into North America, Europe, Asia-Pacific and Rest of the World (RoW) regions. The respective market size for each region and their forecast till 2019 has also been presented in the report. In addition, a qualitative assessment of the market dynamics of the cell surface markers market has been provided, wherein the drivers, restraints, opportunities and market attractiveness has been studied. The competitive landscape section of this report provides a bird's eye view of the major market players currently operating in this market and their respective products. Also, a pipeline snapshot of new entrants in this market along with their development stage products has been included. Key Topics Covered: Chapter 1 Introduction Chapter 2 Executive Summary Chapter 3 Market Overview Chapter 4 Global Cell Surface Markers Market, by Instruments and Reagents Chapter 5 Global Cell Surface Markers Market, by Applications Chapter 6 Global Cell Surface Markers Market, by Geography Chapter 7 Recommendations Chapter 8 Company Profiles List of Figure List of Table Companies Mentioned - Abbott Laboratories, Inc - BD Biosciences - Beckman Coulter, Inc - Bio-Rad Laboratories, Inc - F Hoffmann-La Roche Ltd - Grifols SA - Immucor, Inc - Janssen Diagnostics, Inc - Nihon Kohden Corporation - Siemens Healthcare - Sysmex Corporation - Thermo Fischer Scientific, Inc For more information visit http://www.researchandmarkets.com/research/dbxpsd/cell_surface About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
In Vitro Diagnostic (IVD) Market, Technique & Applications - Forecast To 2017
M2 - Wed Aug 07, 6:40AM CDT
Research and Markets (http://www.researchandmarkets.com/research/wnvq5b/in_vitro) has announced the addition of the "In Vitro Diagnostic (IVD) Market, Technique & Applications - Forecast To 2017" report to their offering. The global in vitro diagnostics market was valued at $49.2 billion in 2012. The factors likely to fuel the growth of the market include on-going developments in analytical laboratory automation, swift progress in various fields of diagnosis such as point-of-care testing, molecular diagnosis, immunoassays, hematology, flow cytometry, microbiology and finally, the geographical market expansion within emerging countries. The most important trend witnessed recently in the in vitro diagnostic industry is that of self-testing as opposed to patients visiting hospitals. This is one of the biggest factors responsible for the growth of point-of-care testing, as patients prefer self-testing to avoid unnecessary visits to the hospital. However, factors such as stringent regulatory frameworks and a shortage of budget are restraining the growth of this market. Key Topics Covered: 1 Introduction 2 Executive Summary 3 Market Overview 4 Global In Vitro Diagnostic Market, By Technique 5 Global In Vitro Diagnostic Market, By Product Type 5.1 Introduction 5.2 Instruments 5.3 Reagents 5.4 Data Management System Software/Hardware 5.5 Services 6 Global In Vitro Diagnostic Market, By Application 6.1 Introduction 6.2 Diabetes 6.3 Infectious Diseases 6.4 Oncology/Cancer 6.5 Cardiology 6.6 Nephrology 6.7 Autoimmune Diseases 6.8 Drug Testing 6.9 HIV/Aids 6.10 Others 7 Global In Vitro Diagnostic Market, By End-User 7.1 Introduction 7.2 Laboratory 7.3 Hospitals 7.4 Academics 7.5 Point-Of-Care Testing 7.6 Patient Self-Testing 7.7 Others 8 Geographic Analysis 9 Competitive Landscape 10 Company Profiles (Overview, Financials, Products & Services, Developments & Strategy)* Companies Mentioned - Abbott Laboratories, Inc - Alere, Inc - Arkray, Inc - Bayer AG - Becton, Dickinson And Company - Bio-Rad Laboratories, Inc - Biomerieux - Danaher Corporation - Diagnostica Stago Sas - Diasorin SPA - Hologic, Inc - Horiba, Ltd - Johnson & Johnson - Novartis International Ag - Qiagen NV - Roche Diagnostics Limited - Siemens Healthcare - Sysmex Corporation - Thermo Fisher Scientific, Inc For more information visit http://www.researchandmarkets.com/research/wnvq5b/in_vitro
Switzerland In Vitro Diagnostics Report complete with information on company financials and pipeline products
M2 - Mon Jul 01, 3:50AM CDT
Research and Markets (http://www.researchandmarkets.com/research/jvbk4h/switzerland_in) has announced the addition of the "Switzerland In Vitro Diagnostics Investment Opportunities, Analysis and Forecasts to 2018" report to their offering. Switzerland In Vitro Diagnostics Investment Opportunities, Analysis and Forecasts to 2018 provides key market data on the Switzerland In Vitro Diagnostics market. The report provides value (USD) million data for each segment and sub-segment within seven market categories - Immuno Chemistry, Clinical Chemistry, Haematology, Infectious Immunology, Microbiology Culture, Histology And Cytology and Genetic Testing. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants with information on company financials and pipeline products, wherever available. Scope - Market size and company share data for In Vitro Diagnostics
Sysmex Renews Agreement to Distribute EasyCell assistant Hematology Imaging System from Medica
PR Newswire - Fri Jun 28, 9:13AM CDT
Sysmex America Inc., the wholly owned U.S. subsidiary of Sysmex Corporation, has announced they have renewed their agreement with Medica Corporation to distribute Medica's EasyCell® assistant for digital cell image analysis in hematology laboratories.
(0)
(0)Sysmex Corp. (SSMXY) Stock Research Links
Scroll down for more posts ▼